Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Ocampo y Esmeralda, Predio CCT, Rosario, Argentina.
Área Biofísica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Santa Fe, Argentina.
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02079-17. Print 2018 Apr.
Metallo-β-lactamases (MBLs) are the major group of carbapenemases produced by bacterial pathogens. The design of MBL inhibitors has been limited by, among other issues, incomplete knowledge about how these enzymes modulate substrate recognition. While most MBLs are broad-spectrum enzymes, B2 MBLs are exclusive carbapenemases. This narrower substrate profile has been attributed to a sequence insertion present in B2 enzymes that limits accessibility to the active site. In this work, we evaluate the role of sequence insertions naturally occurring in the B2 enzyme Sfh-I and in the broad-spectrum B1 enzyme SPM-1. We engineered a chimeric protein in which the sequence insertion of SPM-1 was replaced by the one present in Sfh-I. The chimeric variant is a selective cephalosporinase, revealing that the substrate profile of MBLs can be further tuned depending on the protein context. These results also show that the stable scaffold of MBLs allows a modular engineering much richer than the one observed in nature.
金属β-内酰胺酶(MBLs)是由细菌病原体产生的主要碳青霉烯酶组。MBL 抑制剂的设计受到多种因素的限制,其中包括对这些酶如何调节底物识别的了解不完全。虽然大多数 MBL 是广谱酶,但 B2 MBL 是专有的碳青霉烯酶。这种更窄的底物谱归因于 B2 酶中存在的序列插入,该插入限制了对活性位点的可及性。在这项工作中,我们评估了 B2 酶 Sfh-I 和广谱 B1 酶 SPM-1 中天然存在的序列插入的作用。我们设计了一种嵌合蛋白,其中 SPM-1 的序列插入被 Sfh-I 中的插入所取代。嵌合变体是一种选择性头孢菌素酶,这表明可以根据蛋白质结构域进一步调整 MBL 的底物谱。这些结果还表明,MBL 的稳定支架允许进行比自然界中观察到的更丰富的模块化工程。